Evidence map›Paper›PMID 19712453›Full record

ArticleBMC genomics2009

Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets.

Petronela Ancuta, Kuang-Yu Liu, Vikas Misra, Vanessa Sue Wacleche, Annie Gosselin, Xiaobo Zhou, Dana Gabuzda

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC genomics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03442088 (An Investigator Initiated Study of Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast), which is not on this map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03442088 phase2completednot on this mapstarted 2018, after this paper: background citation

An Investigator Initiated Study of Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast

TypeinterventionalSponsorUniversity Hospitals Cleveland Medical CenterRan2018 to 2021Enrolled28ConditionsPlaque PsoriasisArmsApremilast
3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 275 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Induction of the ISR by AB5 subtilase cytotoxin drives type-I IFN expression in pDCs via STING activation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Macrophage re-programming by JAK inhibitors relies on MAFB.Cellular and molecular life sciences : CMLS · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Cerebrospinal fluid CD14Journal of neurovirology · 2023
    Article
  18. Blockade of IL-6 signaling alleviates atherosclerosis inNature cardiovascular research · 2023
    Article
  19. Article
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Petronela AncutaCRCHUM, Université de Montréal, INSERM Unit 743, Montréal, Québec, Canada. petronela.ancuta@umontreal.ca
Kuang-Yu Liu
Vikas Misra
Vanessa Sue Wacleche
Annie Gosselin
Xiaobo Zhou
Dana Gabuzda
Université de Montréal · CADana-Farber Cancer Institute · USCornell University · USHarvard University · US

Funding

Monocyte Viral Reservoirs in HIV-1 DementiaR01DA016549 · NIDA · DANA-FARBER CANCER INSTITUTE · PI GABUZDA, DANA H. · 2003 to 2007
$2.1M
LPS and Monocyte Activation in HIV NeuropathogenesisR21DA026322 · NIDA · DANA-FARBER CANCER INST · PI GABUZDA, DANA H. · 2008 to 2009
$470k
NIDA NIH HHS DA16549NIDA NIH HHS DA36222NIDA NIH HHS R01 DA016549NIDA NIH HHS R21 DA026322
6 · The paper itself

Abstract

backgroundHuman peripheral blood monocytes (Mo) consist of subsets distinguished by expression of CD16 (FCgammaRIII) and chemokine receptors. Classical CD16- Mo express CCR2 and migrate in response to CCL2, while a minor CD16+ Mo subset expresses CD16 and CX3CR1 and migrates into tissues expressing CX3CL1. CD16+ Mo produce pro-inflammatory cytokines and are expanded in certain inflammatory conditions including sepsis and HIV infection.

resultsTo gain insight into the developmental relationship and functions of CD16+ and CD16- Mo, we examined transcriptional profiles of these Mo subsets in peripheral blood from healthy individuals. Of 16,328 expressed genes, 2,759 genes were differentially expressed and 228 and 250 were >2-fold upregulated and downregulated, respectively, in CD16+ compared to CD16- Mo. CD16+ Mo were distinguished by upregulation of transcripts for dendritic cell (DC) (SIGLEC10, CD43, RARA) and macrophage (MPhi) (CSF1R/CD115, MafB, CD97, C3aR) markers together with transcripts relevant for DC-T cell interaction (CXCL16, ICAM-2, LFA-1), cell activation (LTB, TNFRSF8, LST1, IFITM1-3, HMOX1, SOD-1, WARS, MGLL), and negative regulation of the cell cycle (CDKN1C, MTSS1), whereas CD16- Mo were distinguished by upregulation of transcripts for myeloid (CD14, MNDA, TREM1, CD1d, C1qR/CD93) and granulocyte markers (FPR1, GCSFR/CD114, S100A8-9/12). Differential expression of CSF1R, CSF3R, C1QR1, C3AR1, CD1d, CD43, CXCL16, and CX3CR1 was confirmed by flow cytometry. Furthermore, increased expression of RARA and KLF2 transcripts in CD16+ Mo coincided with absence of cell surface cutaneous lymphocyte associated antigen (CLA) expression, indicating potential imprinting for non-skin homing.

conclusionThese results suggest that CD16+ and CD16- Mo originate from a common myeloid precursor, with CD16+ Mo having a more MPhi - and DC-like transcription program suggesting a more advanced stage of differentiation. Distinct transcriptional programs, together with their recruitment into tissues via different mechanisms, also suggest that CD16+ and CD16- Mo give rise to functionally distinct DC and MPhi in vivo.

Indexed as

Gene Expression ProfilingCell DifferentiationDendritic CellsHumansMacrophagesMonocytesOligonucleotide Array Sequence AnalysisReceptors, IgGRNAReceptors, IgGRNA

Identifiers

PMID19712453
PMCPMC2741492
OpenAlexW2153932008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.